FcRn Proteins for Antibody Recycling and Half-Life Studies

Need an FcRn protein to compare antibody recycling or half-life-extension candidates? Choose a species-matched FCGRT–B2M heterodimer with a tag and immobilization format suitable for testing at acidic and near-neutral pH. Confirm the exact activity method instead of relying on “FcRn” or “active” in the product name. Beta LifeScience offers Human, Cynomolgus/Rhesus macaque, Mouse and Rat FcRn formats. Confirm product suitability, availability, quantity and project-specific documentation before ordering. Request an FcRn Protein Selection Review — send the antibody format, Fc variant, species, assay platform, pH conditions, tag preference and required quantity.

Quick Buying Answer

For most cell-free studies, use a mammalian-expressed FCGRT–B2M extracellular complex. Select Human FcRn for human therapeutic-antibody ranking and add the relevant preclinical species receptor when cross-species translation matters. Choose His-tagged FcRn for compatible capture platforms or an Avi-tagged/biotinylated format for controlled streptavidin capture. Compare acidic engagement with near-neutral release.

Choose the Purchasing Route First

If Human and Cynomolgus proteins will be compared, request both in closely matched construct and tag formats where feasible. This reduces the chance that a format difference will be mistaken for a species effect.

Featured FcRn Proteins to Evaluate

The products below represent different species and capture formats. They are starting options, not complete half-life kits or guarantees of pharmacokinetic performance.

Important activity note: The listed ELISA activity for BLK-02120P and BLK-02121P uses an anti-FcRn antibody. Listed activity should not be read as proof of pH-dependent IgG binding; request assay-specific data. Review the live product page and quote for current availability, pack size, price and documentation. If a listed protein lacks the assay-specific evidence your program requires, request additional evaluation or select a custom route.

What FcRn Selection Must Reproduce

FcRn binds IgG Fc in the acidic endosomal environment and releases it toward the near-neutral extracellular environment. The relevant question is whether an antibody shows the desired species-specific engagement and release profile. Recombinant FcRn can rank candidates, but it does not directly measure serum half-life; PK also depends on target-mediated disposition and other molecular properties.

Buy the FcRn–B2M Heterodimer for Functional Binding Work

FcRn contains the FCGRT heavy chain and β2-microglobulin. For half-life-oriented cell-free work, use a soluble extracellular FCGRT–B2M complex. An isolated FCGRT chain may suit immunogen or detection applications but should not be assumed equivalent to an assembled functional receptor. Before purchase, verify both component sequences, expression host, assembly strategy, tag location, purity or heterodimer evidence, formulation, and the ligand, pH and platform used for any activity claim.

Select Human, Cynomolgus, Mouse or Rat FcRn

Human FcRn

Use Human FcRn to rank human therapeutic antibodies, Fc fusions and engineered Fc variants. It is normally the primary receptor for leads containing a human IgG Fc.

Cynomolgus or Rhesus FcRn

Add a primate receptor when the program includes Cynomolgus or Rhesus PK studies. Assess Human and primate FcRn directly under matched construct, capture and pH conditions rather than assuming equivalent behavior.

Mouse or Rat FcRn

Rodent FcRn suits rodent antibodies, mechanistic controls and studies supporting a defined mouse or rat model. It is not a substitute for Human FcRn, and recombinant binding alone cannot resolve every consideration introduced by transgenic or humanized models.

Choose the Tag and Immobilization Strategy

Do not buy biotinylated FcRn simply because it sounds more assay-ready. Choose it when the planned platform uses streptavidin capture and the biotin format is compatible with the receptor complex. For kinetic analysis, low and controlled ligand density can be as important as nominal purity.

Match the Protein to the Assay Platform

SPR or BLI kinetic studies

SPR and BLI can compare association, dissociation and apparent affinity. Define the immobilized partner, capture chemistry, concentration series and buffers before choosing the FcRn tag. Include acidic binding and near-neutral release conditions.

ELISA or plate-based screening

Plate assays can rank larger antibody panels but are sensitive to coating orientation and avidity, so they do not provide intrinsic kinetics. Streptavidin-captured biotinylated FcRn may offer more controlled orientation than passive coating.

FcRn affinity chromatography

FcRn columns can compare how antibodies bind under acidic conditions and elute as pH increases. This approach evaluates pH-dependent retention across a gradient, but column behavior depends on receptor density and method conditions. If purchasing protein for column coupling, state the resin chemistry, target coupling level and required amount.

Cellular recycling or transcytosis assays

Soluble FcRn does not reproduce endosomal trafficking. Use it to prioritize candidates, then confirm internalization, recycling and the relevant biology in an appropriate cell system and PK model.

Test Acidic Binding and Near-Neutral Release

An Fc-engineered antibody intended for longer persistence should generally engage FcRn under acidic endosomal conditions and release efficiently as the pH approaches physiological conditions. Testing only at one acidic pH can miss unwanted residual binding at neutral pH.

A practical comparison may include:

• wild-type Fc as the reference;
• engineered Fc variants;
• a negative or reduced-binding control where available;
• Human FcRn and the relevant preclinical species FcRn;
• a defined acidic binding condition, commonly around pH 6;
• a near-neutral release or residual-binding condition around pH 7.4;
• replicate concentration series and a blank surface.

Exact buffers, ionic strength, surfactant, temperature and surface density should be consistent across candidates. “Higher affinity” should not be the only purchasing or development goal; the desired pH differential and clean release profile matter.

Active FcRn vs Antigen-Grade FCGRT

“Active” can describe different tests. A product may have been assessed using an anti-FcRn antibody rather than an IgG Fc ligand, or by a platform and pH condition that differs from your study. Activity against one binding partner does not guarantee suitability for antibody-recycling analysis.

For half-life-oriented work, ask for the exact activity method and answer these questions:

1. Was the tested material an FCGRT–B2M heterodimer?
2. Was the ligand an IgG, Fc domain, albumin, anti-FcRn antibody or something else?
3. At what pH was binding measured?
4. Was neutral-pH release or residual binding assessed?
5. Which platform, immobilization orientation and fitting model were used?
6. Are lot-specific data available for the material being purchased?

An antigen-grade FCGRT protein can be appropriate for antibody generation or detection controls. For IgG-recycling studies, select a receptor complex with evidence that matches the intended ligand and method.

Quality Information to Confirm in the Quote

QC scope is product- and project-specific. Not every test is included with every catalog or custom FcRn protein. Confirm included methods, acceptance criteria, documentation and pricing before ordering.

Optional methods may include SEC or another homogeneity assessment, mass confirmation, biotinylation measurement, endotoxin testing and application-specific binding studies. Ask for what the experiment needs rather than assuming the longest QC list is automatically best. Discuss an FcRn Binding Project  provide the species panel, FCGRT/B2M format, antibody or Fc construct, assay platform, pH buffers, tag, quantity and requested binding documentation.

Plan Quantity and Lot Strategy

Calculate protein needs from the assay platform, immobilization level, concentration series, replicates, species panel, optimization work and anticipated repeats. Include material for buffer scouting and surface-density optimization. If the program will screen many antibodies or run over several months, ask about bulk supply, dedicated lots and future production. Avoid ordering a large amount before the format is technically accepted. A smaller feasibility quantity may be more economical for confirming capture, pH response and signal window. Once the method is suitable, scale to a coordinated lot for the full candidate panel.

Common Ordering Mistakes

• Ordering an isolated FCGRT chain when an assembled FCGRT–B2M receptor is required.
• Selecting the wrong species for the therapeutic or preclinical model.
• Assuming an “active” label proves pH-dependent IgG binding.
• Evaluating acidic binding without checking near-neutral release.
• Choosing a tag before defining the immobilization platform.
• Comparing species proteins with different boundaries, tags or capture orientations.
• Ignoring formulation components that may affect coupling or sensor response.
• Treating recombinant binding data as a direct measurement of in vivo half-life.

FAQs

What FcRn protein should I buy for human antibody half-life studies?

Start with a mammalian-expressed Human FCGRT–B2M extracellular heterodimer in a tag format compatible with the assay. Confirm pH-dependent IgG/Fc-binding evidence rather than relying only on the product name.

Is β2-microglobulin required in recombinant FcRn?

For functional cell-free FcRn binding studies, an assembled receptor containing FCGRT and B2M is generally the relevant format. An isolated FCGRT protein may suit immunogen or detection applications.

Should I buy Human and Cynomolgus FcRn together?

Buy both when the program needs human-relevant screening and Cynomolgus translation. Matched formats help separate true species differences from construct or immobilization effects.

Is biotinylated FcRn better than His-tagged FcRn?

Neither is universally better. Biotinylated/Avi-tagged FcRn suits streptavidin capture; His-tagged FcRn fits nickel-based capture and other established methods. The platform determines the better option.

Does stronger FcRn binding always mean longer antibody half-life?

No. Productive recycling depends on pH-dependent binding and release, and in vivo clearance has additional determinants. FcRn results should be interpreted alongside biophysical, cellular and PK data.

Can recombinant FcRn measure antibody recycling directly?

Soluble FcRn measures binding behavior, not intracellular trafficking. Direct recycling or transcytosis questions require a suitable cellular model.

When should I request custom FcRn production?

Request custom evaluation when the needed species, sequence, B2M pairing, tag, biotinylation format, formulation, quantity or assay-specific documentation is unavailable in the catalog.

Conclusion:

The most useful FcRn reagent is not simply the highest-purity receptor on a product list. It is the species-matched FCGRT–B2M complex whose construct, tag, capture strategy and pH-dependent evidence answer the development question. Define those specifications before buying, compare acidic engagement with near-neutral release, and connect the in vitro result to cellular and PK evidence.

Browse FcRn proteins or submit an FcRn project for evaluation. Send the antibody format and Fc variant, required species, assay platform, pH conditions, preferred tag, quantity and QC needs for a catalog, semi-custom or custom recommendation.